Shitij Kapur

Psychiatry and Mental health · 2000–2015

A researcher in the Science corpus: 10 papers; trusts 16 researchers and is trusted by 35 researchers here, as inferred from the citation graph.

Subfields

• Psychiatry and Mental health — 29 citations into it; #21 of 1,338 by trust here, #191 by citations
• Cognitive Neuroscience — 25 citations into it
• Cellular and Molecular Neuroscience — 23 citations into it; #964 of 2,998 by trust here, #1,121 by citations
• Molecular Biology — 15 citations into it; #15,754 of 17,773 by trust here, #11,410 by citations
• Clinical Psychology — 13 citations into it
• Pharmacology — 9 citations into it; #468 of 1,112 by trust here, #862 by citations
• Philosophy — 8 citations into it; #72 of 1,040 by trust here, #104 by citations
• Experimental and Cognitive Psychology — 7 citations into it

Whom Shitij Kapur trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. ChrisD . Frith
2. R. Bentall
3. Marc Laruelle
4. Sarah-Jayne Blakemore
5. Jeremy K. Seamans
6. Rhiannon Corcoran
7. Anissa Abi-Dargham
8. D. M. Wolpert
9. Wolfram Schultz
10. Louise Arseneault

Who trusts Shitij Kapur overall

1. Kent C. Berridge
2. Oliver D. Howes
3. R. McCutcheon
4. Colin G. DeYoung
5. Klaas E. Stephan
6. S. Fatemi
7. Karl J. Friston
8. Tiago V. Maia
9. Quentin J. M. Huys
10. Paul C. Fletcher

Papers from Shitij Kapur's perspective

Ordered by how strongly the researchers Shitij Kapur trusts endorse each paper. Same corpus, a different order for every researcher.

1. Dysfunction of ventral striatal reward prediction in schizophrenia (NeuroImage)
2. Persecutory delusions: a review and theoretical integration. (Clinical Psychology Review)
3. Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review (Journal of Cerebral Blood Flow and Metabolism)
4. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. (Schizophrenia Research)
5. Causal association between cannabis and psychosis: examination of the evidence (British Journal of Psychiatry)
6. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
7. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. (British Journal of Pharmacology)
8. Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. (NeuroImage)
9. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. (Progress in neurobiology)
10. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. (The Lancet)

Their papers

• CNVs conferring risk of autism or schizophrenia affect cognition in controls (2013) — 669 citations
• Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? (2012) — 967 citations
• Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. (2001) — 1,193 citations
• The Maudsley Prescribing Guidelines in Psychiatry (2015) — 874 citations
• The nature of dopamine dysfunction in schizophrenia and what this means for treatment (2012) — 951 citations
• Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology (2010) — 688 citations
• The dopamine hypothesis of schizophrenia: version III--the final common pathway. (2009) — 2,685 citations
• Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. (2003) — 2,768 citations
• Half a century of antipsychotics and still a central role for dopamine D2 receptors. (2003) — 660 citations
• Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. (2000) — 1,097 citations